Organization Announcements

Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.


Paul G. Allen Frontiers Group [to 15 May 2021]
No new digest content identified.


BARDA – U.S. Department of HHS [to 15 May 2021]
No new digest content identified.


BMGF – Gates Foundation [to 15 May 2021]
Press Releases and Statements
Press release May 12, 2021
Postsecondary Value Commission Report Proposes Action to Address Disparities in Economic Returns to College with Regard to Race, Income and Gender
SEATTLE – May 12, 2021: The national Postsecondary Value Commission, supported by the Bill & Melinda Gates Foundation and managed by the Institute for Higher Education Policy (IHEP), released its final findings today using national and institutional data sources confirming wide-ranging disparity in the value of a postsecondary education in terms of race, income and gender.

Statement May 06, 2021
Statement from Gates Foundation CEO Mark Suzman: No barriers should stand in the way of equitable vaccine access
The Bill & Melinda Gates Foundation has been working urgently since January 2020 with a range of partners to help COVID-19 vaccines reach as many people as possible, as quickly as possible. Today, with the heartbreaking surges in India and Brazil, and the lack of vaccines across African countries, it is clear there’s much more to be done.
No barriers should stand in the way of equitable access to vaccines, including intellectual property, which is why we are supportive of a narrow waiver during the pandemic. Those negotiations will occur via the WTO process, led by country negotiators…


Bill & Melinda Gates Medical Research Institute [to 15 May 2021]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.


CARB-X [to 15 May 2021]
05.10.2021  |
CARB-X is funding Australian-biotech SpeeDx to develop a rapid point-of-care diagnostic for sexually transmitted diseases Chlamydia trachomatis and Neisseria gonorrhoeae
CARB-X is awarding SpeeDx, a diagnostics company in Sydney, Australia, up to $1.8 million to develop a rapid test for Chlamydia trachomatis and Neisseria gonorrhoeae, sexually transmitted bacteria that can cause serious infections and that are spreading around the world at alarming rates. SpeeDx is also eligible for $1.9 million in additional funds from CARB-X if the project achieves certain milestones, subject to available funds.


Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 15 May 2021]
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.
:: [NEW] Informed Consent: A Monthly Review – May 2021 is now posted here


CEPI – Coalition for Epidemic Preparedness Innovations [to 15 May 2021]
Latest News
COVAX Manufacturing Task Force to tackle vaccine supply challenges
COVAX has set up a “Manufacturing Task Force” to identify and resolve issues impeding equitable access to vaccines through COVAX.
14 May 2021

CEPI expands global footprint of its COVID-19 vaccine lab network, and opens testing against Variants of Concern
From July 2021, all COVID-19 vaccine developers are invited to use the network to evaluate their candidate vaccines against SARS-CoV-2 variants.
14 May 2021

The vaccines and the variants: CEPI’s work to tackle an evolving threat
The emergence of SARS-CoV-2 variants underscores the urgent need to double down our efforts to bring COVID-19 under control through the deployment of safe and effective vaccines globally.
11 May 202


DARPA – Defense Advanced Research Projects Agency [to 15 May 2021
No new digest content identified.


Duke Global Health Innovation Center [to 15 May 2021]
Last dated update: FRIDAY, April 16, 2021


EDCTP [to 15 May 2021]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
No new digest content identified.


Emory Vaccine Center [to 15 May 2021]
Vaccine Center News
No new digest content identified.


European Vaccine Initiative [to 15 May 2021]
Latest News
No new digest content identified.


FDA [to 15 May 2021]
Press Announcements /Selected Details
May 14, 2021 – Coronavirus (COVID-19) Update: May 14, 2021

May 11, 2021 – Coronavirus (COVID-19) Update: May 11, 2021

May 11, 2021 – FDA In Brief: FDA Finalizes Guidance with Internationally Harmonized Recommendations to Further Support Safe, High-Quality Human Drug Products

May 10, 2021 – Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic
[See U.S. COVID Actions above for detail]


Fondation Merieux [to 15 May 2021]
News, Events
Mérieux Foundation co-organized event
Evidence to actions: countries and communities driving adaptive, evidence-informed approaches to end cholera
May 20, 2021 – Virtual Event


Gavi [to 15 May 2021]
News Releases
12 May 2021
Japan to host Gavi’s COVAX Advance Market Commitment (AMC) Summit
Geneva, 12 May 2021 – The Government of Japan yesterday announced that it will host the virtual Gavi COVAX Advance Market Commitment (AMC) Summit on June 2nd 2021. The event, co-hosted by Japanese Prime Minister H.E. Yoshihide Suga and José Manuel Barroso, Chair of the Gavi Board, will aim to secure at least US $8.3 billion for 2020-21 in order to accelerate access to 1.8 billion COVID-19 vaccine doses for lower-income economies via the Gavi COVAX Advance Market Commitment by raising an additional US$ 2 billion from donors and the private sector in addition to US$ 6.3 billion raised before the campaign was launched at the “One World Protected” event on April 15th…

10 May 2021
Corporations, charities and governments step up support for equitable COVID-19 vaccine access at Vax Live concert
:: Over US$ 60 million raised for the procurement of COVID-19 vaccines for lower-income countries via the Gavi COVAX Advance Market Commitment (COVAX AMC)
:: The United Arab Emirates and Croatia have also committed millions of COVID-19 vaccines doses for lower-income countries
:: The pledges were announced at Global Citizen’s Vax Live Concert on Saturday, co-hosted by Selena Gomez and featuring messages from Prince Harry, the Duke of Sussex, His Holiness Pope Francis and several Heads of State


GHIT Fund [to 15 May 2021]
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
No new digest content identified.


Global Fund [to 15 May 2021]
News & Stories
Global Fund 45th Board Meeting Reports Continued Progress Despite COVID-19 Pandemic
12 May 2021
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria overwhelmingly praised the continued progress of the Global Fund in the past year despite the challenges of the COVID-19 pandemic.


Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 15 May 2021]
No new digest content identified.


Hilleman Laboratories [to 15 May 2021]
Website not responding at inquiry


Human Vaccines Project [to 15 May 2021]
Vaccines in a Year? How About a Few Months?
Nick Jackson, MSc., DLSHTM, Ph.D.
Head of Programs and Technology, Vaccine Research and Development
Coalition for Epidemic Preparedness Innovations (CEPI)


IAVI [to 15 May 2021]
No new digest content identified.



International Coalition of Medicines Regulatory Authorities [ICMRA]
Selected Statements, Press Releases, Research
No new digest content identified.


ICRC [to 15 May 2021]
Selected News Releases, Statements, Reports
No new digest content identified.



International Generic and Biosimilar Medicines Association [IGBA]
IGBA Applauds UK MHRA Biosimilar Guidance Revision: Science-driven Evolution for Sustainable Access to Biologics (May 2021)
The International Generic and Biosimilar medicines Association (IGBA), which represents global manufacturers of generic and biosimilar medicines, welcomes the UK MHRA publication of its updated guidance on the licensing of biosimilar products (10 May 2021). This publication marks a positive milestone in the evolution of evidence requirements for biosimilar approval through the removal of the default need for a comparative efficacy trial, instead basing approval on a comprehensive comparability exercise, including a comparative pharmacokinetics (PK) trial.



Press Releases/Announcements
No new digest content identified.


IFRC [to 15 May 2021]
Selected Press Releases, Announcements
Bangladesh, India, Laos, Nepal, Philippines
Asia: 5.9 million COVID infections overwhelm hospitals
Kuala Lumpur/Delhi/Geneva, 12 May 2021 – The world’s fastest surge of COVID-19 is pushing hospitals and health systems to the brink of collapse as Asia has fast become the global COVID-19 hotspot, suffering more than twice as many new infections than a …
12 May 2021


Institut Pasteur [to 15 May 2021]
Press release
Genetics: Biosynthesis pathway of a new DNA nucleobase elucidated
DNA is composed of nucleobases represented by the letters A, T, G and C. They form the basis of the genetic code and…


IOM / International Organization for Migration [to 15 May 2021]
IOM Supports the UN COVID-19 Vaccination Roll-Out in Yemen
2021-05-11 16:31
Aden – The International Organization for Migration (IOM) has begun its support to the United Nations (UN) COVID-19 vaccination roll-out in Yemen where cases have recently surged. The Organization is providing vaccinations at five health centres in Aden, Ma’rib, Shabwah, Taiz and Lahj.
Yemen received 360,000 COVID-19 vaccine doses through the COVAX Facility on 31 March. The roll-out of the vaccination campaign began on 20 April…


IRC International Rescue Committee [to 15 May 2021]
Media highlights [Selected]
Press Release
Analysis shows 87% of COVID-19 vaccine doses have been given in wealthier countries, despite surges in cases in conflict-affected countries, warns IRC
May 12, 2021


IVAC [to 15 May 2021]
Updates; Events
Webinar: Addressing challenges in vaccination in fragile contexts
Register Now
Description: With COVID-19 vaccines now available worldwide, reaching underserved and vulnerable populations is a priority under the Immunization Agenda 2030 (IA2030). Numerous challenges and operational issues have presented themselves in fragile contexts including vaccine access, risk of vaccine preventable diseases, and vaccine hesitancy. Join the IA2030 Strategic Priority 5 working group for a 90-minute webinar (May 21 at 7:30am ET / 13:30 CET) hosted by the International Vaccine Access Center to discuss vaccinating against COVID-19 in fragile contexts in coordination with the launch of IA2030 at the World Health Assembly.


IVI [to 15 May 2021]
Selected IVI News, Announcements, Events
No new digest content identified.


JEE Alliance [to 15 May 2021]
Selected News and Events
No new digest content identified.


Johns Hopkins Center for Health Security [to 15 May 2021]
Center News
Johns Hopkins Center for Health Security and National Organizations Share Strategies to Improve Crisis Standards of Care Implementation During Future COVID-19 Surges and Beyond
May 13, 2021
[See Milestones above for full text]


MSF/Médecins Sans Frontières [to 15 May 2021]
Latest [Selected Announcements
More oxygen supplies needed to avoid COVID-19 patients “gasping for air”
Press Release 10 May 2021


National Academy of Medicine – USA [to 15 May 2021]
Selected News/Programs
Upcoming Events:
National Organizations Share Strategies to Improve Crisis Standards of Care Implementation During Future COVID-19 Surges and Beyond
May 13, 2021
[See Milestones above for detail]


National Vaccine Program Office – U.S. HHS [to 15 May 2021]
Upcoming Meetings/Latest Updates
No new digest content identified.


NIH [to 15 May 2021]
News Releases
Gene therapy restores immune function in children with rare immunodeficiency
May 11, 2021 — Researchers found that 48 of 50 children retained their replenished immune system function two to three years later and did not require additional treatments for ADA-SCID.


UN OCHA Office for the Coordination of Humanitarian Affairs [to 15 May 2021]
Press Releases
13 May 2021
Humanitarian Coordinator condemns killing of an aid worker in Budi, Eastern Equatoria

10 May 2021
Humanitarian Coordinator condemns attacks against humanitarian workers in Renk, Upper Nile


PATH [to 15 May 2021]
Press Releases
No new digest content identified.


Sabin Vaccine Institute [to 15 May 2021]
Statements and Press Releases
No new digest content identified.


UNAIDS [to 15 May 2021]
Selected Press Releases/Reports/Statements
14 May 2021
Protecting prisoners from HIV and COVID-19 in Mexico

11 May 2021
Community-led HIV services stepped up in the Philippines during the COVID-19 pandemic

10 May 2021
UNAIDS saddened by the death of Smarajit Jana


UNDP United Nations Development Programme [to 15 May 2021]
Latest from News Centre
No new digest content identified.


UNHCR Office of the United Nations High Commissioner for Refugees [to 15 May 2021]
Selected News Releases, Announcements
UNHCR, aid partners call for renewed and strong support for the Rohingya refugees
14 May 2021
… With the refugee crisis in its fourth year, Bangladesh needs robust and sustained international support to ensure the safety and wellbeing of stateless Rohingya refugees. This must not become a forgotten crisis. Both Rohingya refugees and Bangladesh, having generously hosted them for decades, must see the world standing with them.
Adding to the complexity of this crisis, the COVID-19 pandemic has compounded vulnerabilities for refugees and host communities alike. To date, the Government of Bangladesh, with the support of the humanitarian community, has effectively managed the COVID-19 response and the spread of the disease in the Rohingya camps and surrounding areas, though the trajectory of the virus remains unpredictable. A coordinated and inclusive response has saved lives. However, it is critical to ensure the continued delivery of all humanitarian assistance and protection services…


UNICEF [to 15 May 2021]
Selected Press Releases, Statements
Statement 05/10/2021
UNICEF Executive Director Henrietta Fore’s remarks at the European Commission High-Level Conference on the Mental Health Impact of COVID-19
As prepared for delivery
… “Emerging evidence indicates that the mental health impacts will be significant and long-lasting. Especially in the poorest countries and neighbourhoods. And for the most disadvantaged children — those living with disabilities, migrants and refugees, ethnic minorities, or those living in humanitarian settings like conflicts.
“The situation is no different in Europe. In fact, one in five adolescents in Europe is experiencing mental health problems.
“A recent OECD survey of youth organizations found that poor mental health is among the biggest impacts of COVID-19.
“And a recent UNICEF rapid review of the impact of COVID on children and adolescents across 77 countries — including 20 European countries — found that children and adolescents are reporting increased stress, anxiety, and substance use.
“They’re out of school. They’re not seeing their friends. They’re not accessing recreational and social activities. They’re facing abuse or neglect. And so often, they’re afraid of reaching out for help because of cultural norms and stigma, which remains very high.
“At the same time, these young people are coming up against a barrier that affects every person struggling with their mental health — a lack of services.
“All countries — rich and poor alike — are facing a huge gap between mental health needs and access to quality services…”


Unitaid [to 15 May 2021]
Featured News
13 May 2021
Unitaid supports new Global Initiative to end Cryptococcal Meningitis deaths by 2030
Unitaid is pleased to support the new Global Initiative to end Cryptococcal Meningitis deaths by 2030, launched on May 12th 2021 by key partners in the Cryptococcal Meningitis Advocacy Group. This target will help bring renewed focus on preventing the deaths of those living with HIV.
Cryptococcal Meningitis (CM) is a major cause of mortality among people living with HIV, accounting for 15% of the global 690,000 AIDS-related deaths in 2019 alone. An opportunistic infection, it primarily impacts those with weakened immune systems and is fatal if left untreated…


Vaccination Acceptance Research Network (VARN) [to 15 May 2021]
No new digest content identified.


Vaccine Confidence Project [to 15 May 2021]
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).


Vaccine Education Center – Children’s Hospital of Philadelphia [to 15 May 2021]
No new digest content identified.


Wellcome Trust [to 15 May 2021]
News and reports
No new digest content identified.


The Wistar Institute [to 15 May 2021]
Press Releases
Press Release May. 11, 2021
The Wistar Institute Receives Transformative National Science Foundation Grant to Expand and Accelerate STEM Training Program
Impactful, inclusive workforce development program will develop a pipeline of young scientists for careers in growing life sciences sector.


WFPHA: World Federation of Public Health Associations [to 15 May 2021]
Latest News
No new digest content identified.


World Bank [to 15 May 2021]
Selected News, Announcements
World Bank Redeploys $153 Million to Support Pakistan’s COVID-19 Vaccine Drive
WASHINGTON, May 13, 2021—The World Bank’s Board of Executive Directors today approved the restructuring of the Pandemic Response Effectiveness in Pakistan (PREP) project, originally approved in April 2020…
Date: May 13, 2021 Type: Press Release

Antimicrobial Resistance (AMR)
Antimicrobial Resistance (AMR) Antimicrobials are drugs – such as antibiotics – that kill or control disease-causing microbes. Antimicrobial resistance (AMR) occurs when microbes mutate or adapt in…
Date: May 13, 2021 Type: Brief

Widespread Informality Likely to Slow Recovery from COVID-19 in Developing Economies
Study Finds One-Third of Economic Activity Occurs Outside Governments’ Line of Sight WASHINGTON, May 11, 2021—A strikingly large percentage of workers and firms operate outside the line of sight of governments…
Date: May 11, 2021 Type: Press Release Language


World Customs Organization – WCO [to 15 May 2021]
Latest News – Selected Items
No new digest content identified.


World Organisation for Animal Health (OIE) [to 15 May 2021]
Press Releases
No new digest content identified.


WTO – World Trade Organisation [to 15 May 2021]
WTO News and Events
Bolivia outlines vaccine import needs in use of WTO flexibilities to tackle pandemic
12 May 2021
The government of Bolivia has formally notified the WTO of the country’s need to import COVID-19 vaccines, taking another step towards using flexibilities in WTO intellectual property rules as part of its pandemic response.
Bolivia notified the WTO it needed to import 15 million doses of a vaccine under the legal system introduced in a 2017 amendment to the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). That amendment, which created Article 31bis of the TRIPS Agreement, provides an additional legal pathway for import-reliant countries to access affordable medicines, vaccines and other pharmaceutical products.
Bolivia’s submission follows through on its February notification signalling that it intended to exercise the flexibilities under the amendment.
Bolivia’s notification opens up the possibility of importing the needed vaccines from any one of around 50 WTO members that have put in place domestic laws providing for the production and export of medicines made under compulsory licence through this system…





ARM [Alliance for Regenerative Medicine] [to 15 May 2021]
Press Releases – Alliance for Regenerative Medicine (
Press Releases
No new digest content identified.


BIO [to 15 May 2021]
Press Releases
No new digest content identified.


DCVMN – Developing Country Vaccine Manufacturers Network [to 15 May 2021]
News; Upcoming events
No new digest content identified.


ICBA – International Council of Biotechnology Associations [to 15 May 2021]
No new digest content identified.


IFPMA [to 15 May 2021]
Selected Press Releases, Statements, Publications
COVID-19 Biopharmaceutical Industry – Regulatory Guiding Principles (May 2021)
Published on: 11 May 2021
[Formatting/text-bolding from original]
On 14 May 2020, we released our first Regulatory Guiding Principles in the unprecedented and unknown context of the COVID-19 pandemic. One year on and we are still facing the impact of this public health emergency, yet we have seen many advancements and successes. New vaccines against COVID-19 are now available, and multiple new therapeutic medicines are in various stages of the pharmaceutical pipeline. The timelines and pressure behind research and development efforts at such a global scale have never been seen before.
With all the progress that has been made against COVID-19, we risk losing sight of the other activities that transpired to ensure continued biopharmaceutical research, patient supply and access to medicines and vaccines for other conditions than COVID-19. Biopharmaceutical companies were operating and manufacturing in an environment with supply chains that were greatly impacted.
One year ago, we reiterated our continued commitments to four principles focusing on partnership and collaboration, progressing research, maintaining supply, and meeting quality and safety standards. Today, we are still honoring those commitments and are working to implement the best practices and lessons learnt by building stronger systems for the future of global health. The importance of these Regulatory Guiding Principles is clearly evident in what has been achieved during the past, very challenging year.


Working in partnership and collaboration with national regulatory authorities (NRAs) to define the best science-based regulatory strategies for ensuring the availability of COVID-19 medicines and vaccines – We are engaging with NRAs and regulatory coalitions to provide input, as well as feedback, on regulatory agilities, streamlined processes, rolling reviews and reliance principles implemented to accelerate the development and registration of COVID-19 medicines and vaccines. These lessons learned, along with further development and use of digital technologies, will help to modernize the current regulatory environment to better adapt to scientific and technical innovations in a sustainable fashion while providing best practices for future pandemic preparedness.


Progressing research into new treatments and prevention of other conditions – Lockdowns, movement restrictions, and stay-at home recommendations redirected health resources to the front line and away from new and ongoing clinical research for non-COVID-19 treatments. Patient enrollment in new clinical trials and access to existing clinical research sites were initially affected. Keeping participants safe and maintaining clinical trial integrity were priorities and implementation of new technologies like remote monitoring helped improve our recruitment of volunteers, clinical trials conduct, and monitoring and data capture.


Maintaining supply of medicines and vaccines – The manufacture of a medicine frequently requires more than 200 material components, along with a range of technologies. While an initial surge in global demand led to some acute shortages for these components, supply chains overall demonstrated significant resilience during the pandemic. We will continue to work with our partners to identify solutions that address the resilience and reliability of global supply as supported by predictable and agile regulatory processes and requirements.


Ensuring all our medicines and vaccines continue to meet appropriate standards for quality and safety – Quality manufacturing and patient safety monitoring are fundamental to our work and to public health. Even though the biopharmaceutical industry experienced various disruptions to ‘business as usual’ during the pandemic, quality, safety and efficacy of the medicines and vaccines we manufacture remained a key priority. Engagement with regulatory stakeholders will continue to ensure that quality and high-level standards are met.


PhRMA [to 15 May 2021]
Selected Press Releases, Statements
New polling shows Americans are sounding the alarm on the TRIPS IP waiver
May 14, 2021
Once you peel back the layers of the TRIPS waiver and understand the risks to health and safety, recent data shows that Americans want a better way.
Blog Post

The Biden Administration allows politics to upend a pragmatic pandemic response
May 14, 2021
Not only will this policy do nothing to help save lives globally, it could have a damaging impact for American patients.
Blog Post